Drug companies aren't spending enough on research. They should be taxed to fund it

To the editor: The development of drugs such as Sovaldi is one of the crowning achievements of modern medicine, with its promise of eliminating the suffering and costs associated with advanced liver disease. (“We're all paying a high price for drug company profiteering,” Opinion, July 6)

Although...